Welcome to episode 94 of AI in Action, the podcast that breaks down the hype and explores the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.
Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in the United States and Europe.
Today's guest is Rohit Nambisan, President at Lokavant in New York. Lokavant is a technology company whose mission is to ensure that no clinical trial fails due to operational error. By integrating and analyzing the disparate data sources within clinical trials, Lokavant provides real-time visualizations and risk alerts to study sponsors and CROs to enable data-driven decisions. These insights expedite trial timelines and reduce the costs of development, allowing safe and efficacious treatments to get to patients.
Lokavant centralizes trial data to power a machine learning model that anticipates trial risk, provides data-driven risk mitigation strategies and predicts the impact of mitigation strategy implementation. Lokavant's anticipatory monitoring capability is grounded in a compendium of data from over 1,000 clinical trials and will improve with each deployment.
In the show, Rohit will share with you:
How Lokavant aim to impact the Healthcare sector
Using data to positively impact clinical trials
How the Coronavirus pandemic is disrupting clinical trials
Lokovant’s solutions in response to COVID-19
Why he loves working in the Healthtech industry
What the future looks like for Lokavant
What did you make of Rohit's podcast? Where do you see the future of Artificial Intelligence and Machine Learning heading in the next few years? We would love to hear your thoughts on this episode, so please leave a comment below.
If you would like to hear more from AI in Action then please subscribe and don’t forget to like and share with your friends on social media.